Last update 25 Oct 2025

CIK(Ever Supreme Bio)

Overview

Basic Info

Drug Type
CIK therapy
Synonyms-
Target
CD16a
Action
modulators
Mechanism
CD16a modulators(Low affinity immunoglobulin gamma Fc region receptor III-A modulators)
Therapeutic Areas
NeoplasmsNervous System DiseasesDigestive System Disorders+ [5]
Active Indication
Breast CancerColorectal CancerGlioblastoma Multiforme+ [4]
Inactive Indication-
Originator Organization
Ever Supreme Bio Technology Co., Ltd.Ever Supreme Bio Technology Co., Ltd.
Active Organization
Ever Supreme Bio Technology Co., Ltd.Ever Supreme Bio Technology Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhaseIND Approval
First Approval Date-
Regulation-

Related

100 Clinical Results associated with CIK(Ever Supreme Bio)
Login to view more data
100 Translational Medicine associated with CIK(Ever Supreme Bio)
Login to view more data
100 Patents (Medical) associated with CIK(Ever Supreme Bio)
Login to view more data
100 Deals associated with CIK(Ever Supreme Bio)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Breast CancerIND Approval
Taiwan Province
Ever Supreme Bio Technology Co., Ltd.Ever Supreme Bio Technology Co., Ltd.
31 May 2023
Colorectal CancerIND Approval
Taiwan Province
Ever Supreme Bio Technology Co., Ltd.Ever Supreme Bio Technology Co., Ltd.
31 May 2023
Glioblastoma MultiformeIND Approval
Taiwan Province
Ever Supreme Bio Technology Co., Ltd.Ever Supreme Bio Technology Co., Ltd.
31 May 2023
Liver CancerIND Approval
Taiwan Province
Ever Supreme Bio Technology Co., Ltd.Ever Supreme Bio Technology Co., Ltd.
31 May 2023
Lung CancerIND Approval
Taiwan Province
Ever Supreme Bio Technology Co., Ltd.Ever Supreme Bio Technology Co., Ltd.
31 May 2023
Ovarian Epithelial CarcinomaIND Approval
Taiwan Province
Ever Supreme Bio Technology Co., Ltd.Ever Supreme Bio Technology Co., Ltd.
31 May 2023
Pancreatic CancerIND Approval
Taiwan Province
Ever Supreme Bio Technology Co., Ltd.Ever Supreme Bio Technology Co., Ltd.
31 May 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free